Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Two Oncology Nurses Implement Process to Allow Patients to Disconnect Pumps From the Comfort of Their Own Homes
    Chemotherapy
    Two Oncology Nurses Implement Process to Allow Patients to Disconnect Pumps From the Comfort of Their Own Homes
    May 19, 2023
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    Special Populations
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    March 10, 2023
    How I Practice Mindfulness as an Oncology Nurse
    Nurse well-being
    How I Practice Mindfulness as an Oncology Nurse
    March 03, 2023
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Cervical cancer

    More Patients Are Skipping Their Cervical Cancer Screenings
    Research

    More Patients Are Skipping Their Cervical Cancer Screenings

    Nearly a quarter of patients who are eligible for cervical cancer screening are overdue for their current tests, researchers said in study findings published in JAMA Network Open. The number grew nearly 10% since 2005—representing a steady increase in missed screening over time—and was higher in different sociodemographic groups because of factors related to social determinants of health.

    May 04, 2022
    Oncology Drug Reference Sheet: Tisotumab Vedotin-Tftv
    Drug Reference Sheet

    Oncology Drug Reference Sheet: Tisotumab Vedotin-Tftv

    In clinical trials, 24% of patients achieved an objective response rate with tisotumab vedotin-tftv (TivdakTM) that lasted a median of 8.3 months, leading to the agent’s U.S. Food and Drug Administration September 2021 approval for use in adults with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

    February 22, 2022
    CDC Releases Video Series About Gynecologic Cancers as Part of Gynecologic Cancer Campaign
    Patient resources

    CDC Releases Video Series About Gynecologic Cancers

    Multimedia tools and resources can help patients learn more about a cancer diagnosis, treatment regimens, procedures, and follow-up care, among other important topics, and many institutions and organizations have jumped onto the bandwagon to create those resources for their patients. A new video series on gynecologic cancers from the Centers for Disease Control and Prevention (CDC) adds another patient education resource to oncology nurses’ toolbox.

    October 28, 2021
    FDA Approves Pembrolizumab Combination for First-Line Treatment of Cervical Cancer
    U.S. Food and Drug Administration (FDA)

    FDA Approves Pembrolizumab Combination for First-Line Treatment of Cervical Cancer

    On October 13, 2021, the U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda®) in combination with chemotherapy, with or without bevacizumab, for patients with persistent, recurrent, or metastatic cervical cancer whose tumors express PD-L1 (CPS ≥ 1), as determined by an FDA-approved test. 

    October 13, 2021
    FDA Grants Accelerated Approval to Tisotumab Vedotin-Tftv for Recurrent or Metastatic Cervical Cancer
    U.S. Food and Drug Administration (FDA)

    FDA Grants Accelerated Approval to Tisotumab Vedotin-Tftv for Recurrent or Metastatic Cervical Cancer

    On September 20, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to tisotumab vedotin-tftv (Tivdak™), a tissue factor-directed antibody and microtubule inhibitor conjugate, for adult patients with recurrent or metastatic cervical cancer whose disease has progressed on or after chemotherapy.

    September 21, 2021
    Latina, Asian Women With Gynecologic Cancers Are Less Likely to Use Palliative Care
    Research

    Latina, Asian Women With Gynecologic Cancers Are Less Likely to Use Palliative Care

    Only 4%–9% of patients with ovarian or cervical cancer use palliative care, but the numbers are much lower for Hispanic and Asian women than for non-Hispanic White women, according to researchers’ findings reported in Data in Brief.

    April 14, 2021
    ACS Cervical Cancer Screening Guidelines Prefer HPV Over Pap Tests
    Cervical cancer

    ACS Cervical Cancer Screening Guidelines Prefer HPV Over Pap Tests

    People with a cervix who are aged 25–65 years should receive a human papillomavirus (HPV) test every five years, according to the new American Cancer Society (ACS) guidelines for cervical cancer screening.

    November 04, 2020
    Study Links HPV Vaccine to Reduced Rates of Cervical Cancer
    Research

    Study Links HPV Vaccine to Reduced Rates of Cervical Cancer

    Cervical cancer rates have dropped more than 90% among women who received the human papillomavirus (HPV) vaccine, according to the results of a Swedish study published in the New England Journal of Medicine. Global health leaders are calling it a milestone study. 

    October 23, 2020
    January Is Cervical Health Awareness Month
    Health Policy

    January Is Cervical Health Awareness Month

    In 2020, approximately 13,800 new cases of invasive cervical cancer will be diagnosed in the United States. Prevention and screening are critical to reducing its incidence, and the U.S. Department of Health and Human Services (HHS) launched an awareness campaign in January in recognition of Cervical Health Awareness Month. The movement educates women about cervical cancer risks, how and when to get the human papillomavirus (HPV) vaccine, the vaccine’s impact on cancer rates, and how to promote awareness.

    January 21, 2020
    WHO Reports First Global HPV Vaccine Data
    Cancer prevention

    WHO Reports First Global HPV Vaccine Data

    New cancer prevention strategies like the human papillomavirus (HPV) vaccine are making waves throughout the United States and around the world. Evidence has shown that the vaccine can help protect against certain cancers such as cervical, anal, oropharyngeal, penile, vulvar, and vaginal in people who receive the vaccine. For the first time ever, the World Health Organization (WHO) has global data outlining HPV coverage in countries across the globe.  

    November 20, 2019
    CDC Encourages Screening, Vaccination for HPV to Fight Cervical Cancer
    Cancer prevention

    CDC Encourages Screening, Vaccination for HPV to Fight Cervical Cancer

    Recent congressional hearings about vaccination have caused a litany of responses from different members of the public, private, and political sectors. Current Centers for Disease Control and Prevention (CDC) evidence has shown that human papillomavirus (HPV) vaccination has led to fewer cases of HPV-related cancers.  

    March 10, 2019
    What Women Need to Know About Preventing Gynecologic Cancers
    Cancer prevention

    What Women Need to Know About Preventing Gynecologic Cancers

    Not that long ago, women were told to get a Pap test every year. And most of us did, even though it wasn’t always clear why we were being tested. We just did what we were told and thought it was a surefire way to stay healthy. But times and recommendations have changed about what test to have, how often to have it, and the reason to have it. 

    February 19, 2019
    Epigenetic Cervical Cancer Test May Be More Accurate Than Pap or HPV Tests
    Genetics & genomics

    Epigenetic Cervical Cancer Test May Be More Accurate Than Pap or HPV Tests

    An S5 methylation test detected 100% of grade 2 cervical intraepithelial neoplasms or worse, compared to a 50% detection rate for Pap or human papillomavirus (HPV) tests, according to the results of a recent study reported in the International Journal of Cancer.

    February 13, 2019
    HPV Test May Be Better Than Pap Test for Women Older Than 30
    Cancer screening

    HPV Test May Be Better Than Pap Test for Women Older Than 30

    Pap tests have long been the gold standard to screen women for cervical cancer, but a new study published in JAMA says that in women older than 30 years, HPV testing is less invasive and more accurate.  

    August 30, 2018
    Cervical Cancer Awareness and Education Saves Lives
    Cervical cancer

    Cervical Cancer Awareness and Education Saves Lives

    January was cervical health awareness month, and the federal government, along with many advocacy groups, spent considerable time talking about early detection. According to the National Cancer Institute and the U.S. Food and Drug Administration (FDA), cervical cancer is largely preventable. If it’s detected early, it’s often curable too. Many experts say that the key to cervical cancer is vaccination and embracing the two tests used for early detection—Pap smears and human papillomavirus (HPV) testing.

    March 02, 2017
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    • ONS Congress Newscast
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    View All Topics
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲